University of California, San Francisco (UCSF) at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of California, San Francisco (UCSF) takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions span eye side effects of antibody-drug conjugates, digital pathology and genomic testing in routine care. It presents AI-driven digital pathology validated for a gene-based recurrence signature in early-stage breast cancer, and a nurse-led effort to build genomic testing into cancer centre workflows.

OrganizationESMO 2026 Attendance
ucsf.edu
University & institute
Public health sciences university in San Francisco, California, with a medical school and a comprehensive cancer centre.
Talk
Sat Oct 24
15:35–16:00
Eye toxicities
Emerging toxicities induced by antibody-drug conjugates
Nursing & supportive care
Abstract
Sat Oct 24
15:39–15:49
Talk
Mon Oct 26
15:50–15:55

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of California, San Francisco (UCSF)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction